Nepean Blue Mountains Local Health District Human Research Ethics
In Australia, the ethics of human research is governed by the National Statement on Ethical Conduct in Human Research (2007) - updated Dec 2013 issued by the National Health and Medical Research Council (NHMRC). Under these guidelines all research involving humans requires ethical approval. Within the Nepean Blue Mountains Local Health District (NBMLHD) this responsibility is undertaken by a Human Research Ethics Committee (HREC), supported by a Scientific Advisory Committee (SAC) which includes scientific and drug review.
NBMLHD Human Research Ethics Committee (HREC)
The core membership of the NBMLHD Human Research Ethics Committee (HREC) complies with the National Statement in that it includes a chairperson, six lay people (comprising both men and women), a minister of religion, a lawyer, medical clinicians / scientists with research experience and a professional carer/social worker (nurse / allied health). Additional members represent the main areas of medical research within the Nepean Blue Mountains Local Health District.
The NBMLHD HREC reviews applications for single site research; it is also accredited as a lead HREC under the NSW Ministry of Health’s Model for Single Ethical & Scientific Review of Multi-Centre Research. This means that it is able to review applications for multi-centre research being undertaken in NSW public health organisations. With the recent implementation of Mutual Acceptance between New South Wales, Queensland and Victoria (for clinical trials only) and the future introduction of the NHMRC’s Harmonisation of Multi-Centre Ethical Review (HoMER), accreditation has also been granted for the NBMLHD HREC to operate as a lead site under both these schemes.
The HREC reviews applications for single site research to be conducted at facilities and services within the Nepean Blue Mountains Local Health District.
The HREC meets eleven times per year and considers many new applications as well as reviewing the progress and compliance of all currently approved studies.
NBMLHD Scientific Advisory Committee (SAC)
All research proposals are reviewed by the Scientific Advisory Committee (SAC). This committee has the responsibility and expertise for reviewing studies /clinical trials (with respect to scientific rationale, study design, toxicology, pharmacology) to ensure that the expected benefits to participants outweigh the possible side effects. Studies involving devices are also reviewed by the NBMLHD Biomedical Department.
On completion of the review and when SAC has no further concerns, it then forwards their recommendations to the HREC for ethical consideration.
All correspondence to the NBMLHD HREC should be addressed to:
Human Research Ethics Committee
Kingswood NSW 2747
PO Box 63
Penrith NSW 2751
Telephone: 0247 34 3441
NOTE: All correspondence must include the Study Title and (once known) the local HREC reference number and/or AU RED reference no. eg. HREC/13/NEPEAN/123
Monday, 19 June 2017 11:52:01 AM